Transaction expected to approximately triple NEXGEL’s annual revenue to about $35 million and is expected to make the Company immediately profitable upon closing Licensing and acquiring a diversified ...
Axsome Therapeutics (NASDAQ:AXSM) executives provided updates on the company’s commercial portfolio and pipeline during a discussion hosted by Leerink Partners biopharma analyst Marc Goodman. Mark ...
NBA commissioner Adam Silver says expansion talks are coming. See who Seattle and Las Vegas would pick in a mock draft.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results